Antibodies Cytokines Inflammatory myopathy Anti-Mi2 Amyotrophy Lysosomal storage diseases Adjudication Anti-MDA5 autoantibodies Case reports AAV antibody AAV humoral immunity Fabry disease Aldosterone Anti-synthetase syndrome Auto‐antibodies Interferon Anticorps spécifique des myosites Adeno-associated virus vector Cancer Antiphospholipid syndrome AAV Humans Autoimmune diseases Biomarqueurs Inclusion body myositis Anti-drug antibodies Skeletal muscle Autoantibody Adeno-associated vector Agalsidase IBM Immunotherapy Adult Polymyositis Pharmacology Anti-IgE IgG AAV vector Cardio-oncology Autoimmunity Female Biopsy Analyses multidimensionnelles Aged Autoantibodies Interstitial lung disease Acid-alpha-glucosidase Adverse drug reactions DM Adolescence Immune checkpoint inhibitors Myocarditis Systems biology Idiopathic inflammatory myopathies Animals Auto-antibodies B-lymphocyte Dependovirus/genetics/immunology Bioelectrical impedance analysis Sphingosine-1-phosphate IMNM Myositis Arthritis Anti-interleukin-6 Prognosis Auto-immunité B cell homeostasis Anémie hémolytique Myopathy Anti-agalsidase antibodies Male Outcome measures Antibody responses Antisynthetase syndrome Antisynthetase Amyotrophic lateral sclerosis Multidisciplinarity Acute Kidney Injury/epidemiology/etiology Biomarkers Mass cytometry COVID-19 Assisted communication devices Aldostérone Myositis and muscle disease Inborn errors of metabolism Active Anti‐mitochondrial antibodies Dermatomyositis AAV vectors Antisynthétase Muscle Machine learning Data integration Biomarker Anticorps anti-agalsidase Gene therapy Deep immune profiling Inflammation Middle Aged Abnormal movement Adeno-associated virus